Stock Information
Denali Therapeutics Inc (DNLI)
Ticker Symbol: DNLI
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $3,028.57 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -2.969
Revenue (TTM): $0.00 M
Dividend Yield: N/A%
ROE: -50.13%
Latest News
-
Denali Therapeutics shares are trading higher after the company announced it secured $200 million in gross proceeds under the Royalty Agreement.
Tue, Mar 31, 2026 9:09 AM
-
Denali Therapeutics Secures $200M Royalty Funding Following U.S. FDA Accelerated Approval Of Tividenofusp Alfa
Tue, Mar 31, 2026 8:36 AM
Key Financials
Financial data not available
